Status:
COMPLETED
Fat Distribution in Healthy Early Postmenopausal Women
Lead Sponsor:
Bayer
Conditions:
Healthy
Postmenopause
Eligibility:
FEMALE
48-60 years
Phase:
PHASE4
Brief Summary
The aim of this study is to explore the effects of hormone replacement therapy with EV/DNG on abdominal fat distribution measured by magnetic resonance imaging.
Detailed Description
The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.Bayer Schering Pharma AG, Germany is the sponsor of the trial.
Eligibility Criteria
Inclusion
- Healthy early postmenopausal women
- BMI between 25 and 30
Exclusion
- Contra-indication(s) for hormone treatment
- Metabolic diseases
- Concomitant medication with influence on lipid metabolism
Key Trial Info
Start Date :
July 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2004
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT00335218
Start Date
July 1 2002
End Date
August 1 2004
Last Update
December 30 2014
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Vienna, Vienna, Austria, 1090
2
Vienna, Austria, 1060
3
Vienna, Austria, 1200